⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Haisco Pharmaceutical Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Haisco Pharmaceutical Group
↗Shannan, China
Haisco Pharmaceutical Group is a fully integrated, publicly listed Chinese pharmaceutical company founded in 2000. It specializes in the research, development, manufacturing, and commercialization of innovative drugs, with a strong focus on anesthesia, analgesia, oncology, and central nervous system (CNS) disorders.
The company operates globally with R&D outposts in Chengdu, Shanghai, and Silicon Valley. Haisco-USA Pharmaceuticals, Inc. serves as its U.S. subsidiary, focusing on clinical development and expansion into Western markets. The group is recognized for its robust pipeline of novel chemical entities (NCEs) and advanced technology platforms, including PROTACs and antibody-drug conjugates (ADCs).
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Founded:2000
Ownership:public
Status:operating
STOCK
Exchange:Shenzhen Stock Exchange
Ticker:002653
Market Cap:~$12.3B (CNY 87.9B)
PIPELINE
Stage:Phase 3
Lead Drug Stage:Commercial (Ciprofol/HSK3486 approved in China)
Modalities:Small molecule, PROTAC, ADC
Active Trials:231
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Haisco-USA Pharmaceuticals, Inc.
Key Partnerships:Eli Lilly (Research collaboration for innovative targets), AbbVie (Non-opioid pain treatments), Chiesi Group (DPP1 inhibitor), Alumis (TYK2 inhibitor), AirNexis Therapeutics (Lung disease asset)
COMPETITION
Position:Challenger
Competitors:Eli Lilly, AbbVie, Roche, Novartis
LEADERSHIP
Key Executives:
Pangke Yan - CEO
LINKS
Website:haisco-usa.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Haisco Pharmaceutical Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.